Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

Share Price is delayed by 15 minutes
Get Live Data
70.40    0.10 (0.14%)
Bid:
69.50
Ask:
71.80
Spread: 2.30 (3.309%)
Market Cap: £384.18m
FSFL Live PriceLast checked at - London Stock Exchange

Intraday Foresight Solar Fund Share Chart

Director/PDMR Shareholding

23 Sep 2025 17:14

RNS Number : 5104A
Foresight Solar Fund Limited
23 September 2025
Β 

23 September 2025

Foresight Solar Fund Limited

(the "Company")

Director / PDMR Notification

The Company announces that Tony Roper, Non-Executive Director of the Company, being persons discharging managerial responsibilities ("PDMR"), has on 22 September 2025, acquired 40,000 Ordinary Shares in the Company at a price of 0.76100 GBP per share.

In total, Tony Roper has an interest in 95,000 Ordinary Shares and 34,725 Ordinary Shares held via a family investment company. While Tony Roper controls the decision-making of the shares, the economic benefit is solely for his children, the total shareholding represents approximately 0.0213% of the Company's issued Ordinary Share Capital.

PDMR Notification Form:

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further details:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Anthony Charles Roper

2.

Reason for the Notification

a)

Position/status

PDMRNon-Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Foresight Solar Fund Limited

b)

LEI

213800VO4O83JVSSOX33

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

JE00BD3QJR55

b)

Nature of the Transaction

Acquisition of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.76100 GBP

40,000

d)

Aggregated informationAggregated volume Price

40,000 ordinary shares in aggregate30,440.00 GBP

e)

Date of the transaction

22 September 2025

f)

Place of the transaction

Β London Stock Exchange, XLON

ENDS

Foresight GroupMatheus Fierro

fsflir@foresightgroup.euΒ 

+44 (0)20 3911 2318

JTC (Jersey) Limited Hilary Jones ForesightCosec@jtcgroup.com

+44 (0) 1534 700 000

Β 

LEI: 213800VO4O83JVSSOX33

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBLGDCBBDDGUX
Date   Source Headline
2nd Sep 20253:38 pmRNSHolding(s) in Company
1st Sep 20254:59 pmRNSTransaction in Own Shares
29th Aug 20255:03 pmRNSTotal Voting Rights
29th Aug 20254:54 pmRNSTransaction in Own Shares
28th Aug 20255:00 pmRNSTransaction in Own Shares
27th Aug 20254:50 pmRNSTransaction in Own Shares
27th Aug 20257:00 amRNSBattery Portfolio Update
26th Aug 20255:06 pmRNSTransaction in Own Shares
22nd Aug 20254:48 pmRNSTransaction in Own Shares
21st Aug 20253:47 pmRNSTransaction in Own Shares
20th Aug 20255:02 pmRNSTransaction in Own Shares
19th Aug 20254:56 pmRNSTransaction in Own Shares
18th Aug 20254:53 pmRNSTransaction in Own Shares
18th Aug 20257:00 amRNSNotice of Results
15th Aug 20254:51 pmRNSTransaction in Own Shares
14th Aug 20254:50 pmRNSTransaction in Own Shares
13th Aug 20254:52 pmRNSTransaction in Own Shares
12th Aug 20254:55 pmRNSTransaction in Own Shares
11th Aug 20254:57 pmRNSTransaction in Own Shares
8th Aug 20254:56 pmRNSTransaction in Own Shares
7th Aug 20255:06 pmRNSTransaction in Own Shares
6th Aug 20255:04 pmRNSTransaction in Own Shares
6th Aug 20257:00 amRNSQ2 2025 Net Asset Value and Trading Update
5th Aug 20254:51 pmRNSTransaction in Own Shares
5th Aug 202512:28 pmRNSHolding(s) in Company
4th Aug 20254:57 pmRNSTransaction in Own Shares
1st Aug 20254:54 pmRNSTransaction in Own Shares
31st Jul 20255:01 pmRNSTotal Voting Rights
31st Jul 20254:55 pmRNSTransaction in Own Shares
30th Jul 20256:19 pmRNSHolding(s) in Company
29th Jul 20254:53 pmRNSTransaction in Own Shares
28th Jul 20254:56 pmRNSTransaction in Own Shares
25th Jul 20254:55 pmRNSTransaction in Own Shares
24th Jul 202510:05 amRNS-RQuotedData's In The HotSeat Special
23rd Jul 20254:58 pmRNSTransaction in Own Shares
22nd Jul 20254:57 pmRNSTransaction in Own Shares
21st Jul 20254:58 pmRNSTransaction in Own Shares
18th Jul 20254:58 pmRNSTransaction in Own Shares
17th Jul 20254:57 pmRNSTransaction in Own Shares
16th Jul 20257:00 amRNSShare buyback programme extension
14th Jul 20251:38 pmRNSHolding(s) in Company
10th Jul 20255:03 pmRNSTransaction in Own Shares
9th Jul 20254:54 pmRNSTransaction in Own Shares
8th Jul 20254:57 pmRNSTransaction in Own Shares
4th Jul 20254:52 pmRNSTransaction in Own Shares
3rd Jul 20255:01 pmRNSTransaction in Own Shares
2nd Jul 20254:55 pmRNSTransaction in Own Shares
1st Jul 20254:59 pmRNSTransaction in Own Shares
30th Jun 20255:08 pmRNSTotal Voting Rights
30th Jun 20255:04 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.